1. 1223 Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands. (September 2015) Authors: De Meijer, C.; Baka, A.; Leliveld-Kors, A.; Noordzij, W.; Gaultney, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0348 Cost Comparison of Abatacept and Adalimumab Based on Ample, A 2-Year Head-to-Head Outcomes Study in Rheumatoid Arthritis. (9th June 2015) Authors: Gaultney, J.; Budd, D.; Nappi, C.; Benucci, M.; Iannazzo, S.; Alemao, E.; Sabater, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0615 Cost per Response for Abatacept Compared with Adalimumab in The Treatment of Patients with Rheumatoid Arthritis Based on anti-citrullinated Protein Antibody Titres in Italy, Spain and Canada. (15th July 2016) Authors: Foo, J.; Mennini, F.; Rodriguez Heredia, J.M.; Choquette, D.; Attina, G.; Jiménez Merino, S.; Mtibaa, M.; Alemao, E.; Gaultney, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗